NowPow gives SDoH support to Chicago's public health department, Blue Marble...
NowPow, a community referral network seeking to address social determinants of health, has partnered with the Chicago Department of Public Health (CDPH) to strengthen its local digital infrastructure...
View ArticleKaia Health raises €62M Series C funding for MSK and COPD care
New York-based Kaia Health has completed a €62 million ($75m) Series C funding round to expand clinical capabilities and treatment services for Musculoskeletal (MSK) and Chronic obstructive pulmonary...
View ArticleUK healthtech company my mhealth and collaborators awarded €2.5M Eurostars...
NHS-approved digital therapeutics company, my mhealth, along with three European collaborators, have been awarded a €2.5 million Eurostars Grant for the development of their project, CUOREMA.Eurostars...
View ArticleWellinks scores $25M for digital COPD management
Wellinks, the company behind a digital platform and connected devices for chronic obstructive pulmonary disease, raised $25 million in Series C funding. The round was led by Morningside Ventures with...
View ArticleAdherium gets US FDA 510(k) to connect remote monitoring sensor for Ellipta...
Adherium, a New Zealand-based maker of connected respiratory medical devices, has received the US Food and Drug Administration's 510(k) clearance for connecting its digital monitoring platform with...
View ArticleRoundup: Lunit INSIGHT CXR comes to Brazil and more briefs
LifeSemantics teases pulmonary rehabilitation DTx South Korean digital health company LifeSemantics is launching its digital therapeutics product that helps with the pulmonary rehabilitation of people...
View ArticleSingaporean startup Respiree gets US FDA 510(k) for respiration monitor
Respiree, a med tech spinoff of Singapore's Agency for Science, Technology and Research, has obtained the United States Food and Drug Administration's 510(k) clearance for its wearable...
View ArticleWellinks announces new CEO
Wellinks, the company behind a digital platform and connected devices for chronic obstructive pulmonary disease, has appointed Stacie Bratcher as CEO, filling the position left vacant by Alex Waldron...
View ArticleAevice Health takes on US, Southeast Asia markets
Singapore-based medtech Aevice Health has received undisclosed funding from venture capitalist East Ventures for its expansion in Southeast Asia.It has also announced that its flagship product, the...
View ArticleMark Cuban Cost Plus Drug Company partners with pharma company, COPD Foundation
Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with multinational pharmaceutical company Lupin Limited and the COPD Foundation to expand access to Tiotropium Bromide Inhalation Powder for...
View Article